Search

everythinglearnresearchcommunity

for

Search:↓

The study found that 7.21% of young girls have polycystic ovarian syndrome, with symptoms like irregular periods, abnormal hair growth, and acne. Early diagnosis is important to prevent long-term complications.

Metformin helps improve menstrual irregularities and some hormone levels in PCOS patients, but not symptoms like excess hair, acne, or hair loss.

Metformin reduces certain hormone levels in men with early-onset hair loss.

Women with schizophrenia on atypical antipsychotics are more likely to have polycystic ovarian syndrome (PCOS) than women without schizophrenia.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The most common skin problems in polycystic ovarian disease are hirsutism and acne, and managing these symptoms is key for treatment.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

The new rodent model successfully mimics non-lean human PCOS symptoms.

A woman had a rare liver tumor causing male-like physical changes, highlighting the need for thorough checks when such symptoms appear.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Low estrogen compared to androgen may cause female hair loss.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Serum triglyceride levels are not linked to prostate cancer risk.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.